J SURG ONCOL 润色咨询

JOURNAL OF SURGICAL ONCOLOGY

出版年份:暂无数据 年文章数:5451 投稿命中率: 开通期刊会员,数据随心看

出版周期:Semimonthly 自引率:3.7% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2292690, encodeId=6240229269039, content=稿约:每份手稿仅允许一名(1)名通讯作者。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Wed Dec 10 15:03:39 CST 2025, time=2025-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532404, encodeId=2a1d5324048f, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:投过3次,前2次都是3天之内秒拒,这次送审了,一审20多天,只有1个审稿人意见,大修,修回后二审20多天接收。不错的杂志。意外的是还是该期封面文章,不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=574, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ecd71631888, createdName=gly123, createdTime=Thu Feb 02 22:18:00 CST 2017, time=2017-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2245576, encodeId=06f322455e680, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤;基因<br>经验分享:杂志说录取率15%,投稿6天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202404/a5114d14865f42a28d62bef59e7f68b0-90NEwo6wNuqf.jpg, createdBy=976b8410850, createdName=ms3000000397330826, createdTime=Mon Dec 30 13:12:59 CST 2024, time=2024-12-30, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2226050, encodeId=06ef222605029, content=六天被拒稿了,速度挺快的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad709448387, createdName=ms1000001503174164, createdTime=Mon Sep 16 01:44:40 CST 2024, time=2024-09-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1001197, encodeId=e9f8100119e94, content=有没有大佬遇到投稿系统登陆失败的情况呢?一直显示账号密码错误。修改多次依旧报错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIsjYkp2Kl5shib2jnlaftRccumbKXfJaXIoR1f8DoW7czb9LTIicgjkQUujxbibq58SRYQOfT8vc2Ww/0, createdBy=91e52207571, createdName=Doctor.Li, createdTime=Tue Jul 20 17:21:16 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589865, encodeId=1c31589865da, content=同问<span class="quote">hemeifeng2009 2018-10-06 00:00:00 发表:<br>该杂志最近接收本人一篇胃癌相关Meta分析,由于自身但耽误两个月,总历程6个月。 4月23日投稿,6月份杂志给予审稿意见,本人稍有耽误(期限3个月),惭愧,真的3个月整才修回(增加““未来展望”+文章润色)。注意:语言要求程度很高 R.1。 9月初,修稿再投稿,9月中旬审稿意见:增加“详细摘要” R.2。 9月中旬,修稿再投稿,9月底杂志给予审稿意见:要求删除错误引用的一篇文献 R.3。 10月5日,终于收到主编审稿意见,予以接收(accepted revision R.3)。 本人的疑问是: 1.杂志社编辑鼓励作者申请封面,请问各位前辈封面费用一般是多少? 2.杂志投稿说明只要有彩图收费,本稿【黑白图但无彩图、Open Access选择NO】晚辈想进一步请教,没有任何费用对吧?</span>, beContent=hemeifeng2009 2018-10-06 00:00:00 发表: 该杂志最近接收本人一篇胃癌相关Meta分析,由于自身但耽误两个月,总历程6个月。 4月23日投稿,6月份杂志给予审稿意见,本人稍有耽误(期限3个月),惭愧,真的3个月整才修回(增加““未来展望”+文章润色)。注意:语言要求程度很高 R.1。 9月初,修稿再投稿,9月中旬审稿意见:增加“详细摘要” R.2。 9月中旬,修稿再投稿,9月底杂志给予审稿意见:要求删除错误引用的一篇文献 R.3。 10月5日,终于收到主编审稿意见,予以接收(accepted revision R.3)。 本人的疑问是: 1.杂志社编辑鼓励作者申请封面,请问各位前辈封面费用一般是多少? 2.杂志投稿说明只要有彩图收费,本稿【黑白图但无彩图、Open Access选择NO】晚辈想进一步请教,没有任何费用对吧?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c01577709, createdName=zhanyu, createdTime=Tue Apr 28 00:00:00 CST 2020, time=2020-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109602, encodeId=4b5b2109602c5, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肝癌<br>经验分享:2023.1.6投稿,1.9拒稿,,,审稿是够快的,理由也不给一个。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32418460254, createdName=ms3000000907122076, createdTime=Tue Jan 10 00:46:10 CST 2023, time=2023-01-10, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2108068, encodeId=a765210806830, content=偏重的研究方向:肿瘤;癌症;预后<br>经验分享:11.30投稿unde r review 12.29一审意见回来,副主编和一个审稿人分别提了一个意见,给了3个月修改时间,已返修过去,期待好结果,总体速度很快了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8775398331, createdName=ms5000000029332336, createdTime=Thu Dec 29 20:34:08 CST 2022, time=2022-12-29, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2097425, encodeId=23e8209e425d9, content=请问这个杂志有选项可以不收版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a235198854, createdName=14735239m04暂无昵称, createdTime=Sun Oct 30 08:55:48 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097473, encodeId=a6f5209e4730f, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:癌症;临床<br>经验分享:<a href='/topic/show?id=5769104e42a9' target=_blank style='color:#2F92EE;'>#临床回顾性分析#</a> 【HU】投稿经验分享 赠人玫瑰🌹 10-1submitted 10-1 under review 10-27 awaiting EIC Decision 10-29 Reject Reject letter具体内容如下: Your manuscript entitled, "..........," (JSO-2022-....) was reviewed by the Editorial Committee of Journal of Surgical Oncology. After careful consideration, the manuscript was not recommended for publication in the Journal. This decision reflects the priority that the manuscript was assigned in relation to competing submissions. 总结:审稿较快,偏向于临床大样本研究,病例数低于100的回顾性分析基本不收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104742, encryptionId=5769104e42a9, topicName=临床回顾性分析)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210222/80bdeec0f3f34445aac0344bb5d0ca22/eafe07d5604f4c0a85d42d0f35be2184.jpg, createdBy=2ae15443834, createdName=小白先生, createdTime=Sun Oct 30 15:14:09 CST 2022, time=2022-10-30, status=1, ipAttribution=)]
    2025-12-10 匿名用户

    稿约:每份手稿仅允许一名(1)名通讯作者。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2292690, encodeId=6240229269039, content=稿约:每份手稿仅允许一名(1)名通讯作者。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Wed Dec 10 15:03:39 CST 2025, time=2025-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532404, encodeId=2a1d5324048f, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:投过3次,前2次都是3天之内秒拒,这次送审了,一审20多天,只有1个审稿人意见,大修,修回后二审20多天接收。不错的杂志。意外的是还是该期封面文章,不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=574, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ecd71631888, createdName=gly123, createdTime=Thu Feb 02 22:18:00 CST 2017, time=2017-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2245576, encodeId=06f322455e680, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤;基因<br>经验分享:杂志说录取率15%,投稿6天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202404/a5114d14865f42a28d62bef59e7f68b0-90NEwo6wNuqf.jpg, createdBy=976b8410850, createdName=ms3000000397330826, createdTime=Mon Dec 30 13:12:59 CST 2024, time=2024-12-30, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2226050, encodeId=06ef222605029, content=六天被拒稿了,速度挺快的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad709448387, createdName=ms1000001503174164, createdTime=Mon Sep 16 01:44:40 CST 2024, time=2024-09-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1001197, encodeId=e9f8100119e94, content=有没有大佬遇到投稿系统登陆失败的情况呢?一直显示账号密码错误。修改多次依旧报错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIsjYkp2Kl5shib2jnlaftRccumbKXfJaXIoR1f8DoW7czb9LTIicgjkQUujxbibq58SRYQOfT8vc2Ww/0, createdBy=91e52207571, createdName=Doctor.Li, createdTime=Tue Jul 20 17:21:16 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589865, encodeId=1c31589865da, content=同问<span class="quote">hemeifeng2009 2018-10-06 00:00:00 发表:<br>该杂志最近接收本人一篇胃癌相关Meta分析,由于自身但耽误两个月,总历程6个月。 4月23日投稿,6月份杂志给予审稿意见,本人稍有耽误(期限3个月),惭愧,真的3个月整才修回(增加““未来展望”+文章润色)。注意:语言要求程度很高 R.1。 9月初,修稿再投稿,9月中旬审稿意见:增加“详细摘要” R.2。 9月中旬,修稿再投稿,9月底杂志给予审稿意见:要求删除错误引用的一篇文献 R.3。 10月5日,终于收到主编审稿意见,予以接收(accepted revision R.3)。 本人的疑问是: 1.杂志社编辑鼓励作者申请封面,请问各位前辈封面费用一般是多少? 2.杂志投稿说明只要有彩图收费,本稿【黑白图但无彩图、Open Access选择NO】晚辈想进一步请教,没有任何费用对吧?</span>, beContent=hemeifeng2009 2018-10-06 00:00:00 发表: 该杂志最近接收本人一篇胃癌相关Meta分析,由于自身但耽误两个月,总历程6个月。 4月23日投稿,6月份杂志给予审稿意见,本人稍有耽误(期限3个月),惭愧,真的3个月整才修回(增加““未来展望”+文章润色)。注意:语言要求程度很高 R.1。 9月初,修稿再投稿,9月中旬审稿意见:增加“详细摘要” R.2。 9月中旬,修稿再投稿,9月底杂志给予审稿意见:要求删除错误引用的一篇文献 R.3。 10月5日,终于收到主编审稿意见,予以接收(accepted revision R.3)。 本人的疑问是: 1.杂志社编辑鼓励作者申请封面,请问各位前辈封面费用一般是多少? 2.杂志投稿说明只要有彩图收费,本稿【黑白图但无彩图、Open Access选择NO】晚辈想进一步请教,没有任何费用对吧?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c01577709, createdName=zhanyu, createdTime=Tue Apr 28 00:00:00 CST 2020, time=2020-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109602, encodeId=4b5b2109602c5, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肝癌<br>经验分享:2023.1.6投稿,1.9拒稿,,,审稿是够快的,理由也不给一个。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32418460254, createdName=ms3000000907122076, createdTime=Tue Jan 10 00:46:10 CST 2023, time=2023-01-10, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2108068, encodeId=a765210806830, content=偏重的研究方向:肿瘤;癌症;预后<br>经验分享:11.30投稿unde r review 12.29一审意见回来,副主编和一个审稿人分别提了一个意见,给了3个月修改时间,已返修过去,期待好结果,总体速度很快了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8775398331, createdName=ms5000000029332336, createdTime=Thu Dec 29 20:34:08 CST 2022, time=2022-12-29, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2097425, encodeId=23e8209e425d9, content=请问这个杂志有选项可以不收版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a235198854, createdName=14735239m04暂无昵称, createdTime=Sun Oct 30 08:55:48 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097473, encodeId=a6f5209e4730f, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:癌症;临床<br>经验分享:<a href='/topic/show?id=5769104e42a9' target=_blank style='color:#2F92EE;'>#临床回顾性分析#</a> 【HU】投稿经验分享 赠人玫瑰🌹 10-1submitted 10-1 under review 10-27 awaiting EIC Decision 10-29 Reject Reject letter具体内容如下: Your manuscript entitled, "..........," (JSO-2022-....) was reviewed by the Editorial Committee of Journal of Surgical Oncology. After careful consideration, the manuscript was not recommended for publication in the Journal. This decision reflects the priority that the manuscript was assigned in relation to competing submissions. 总结:审稿较快,偏向于临床大样本研究,病例数低于100的回顾性分析基本不收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104742, encryptionId=5769104e42a9, topicName=临床回顾性分析)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210222/80bdeec0f3f34445aac0344bb5d0ca22/eafe07d5604f4c0a85d42d0f35be2184.jpg, createdBy=2ae15443834, createdName=小白先生, createdTime=Sun Oct 30 15:14:09 CST 2022, time=2022-10-30, status=1, ipAttribution=)]
    2017-02-02 gly123

    审稿速度:1.0 | 投稿命中率:25.0
    经验分享:投过3次,前2次都是3天之内秒拒,这次送审了,一审20多天,只有1个审稿人意见,大修,修回后二审20多天接收。不错的杂志。意外的是还是该期封面文章,不错。

    2

    展开2条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2292690, encodeId=6240229269039, content=稿约:每份手稿仅允许一名(1)名通讯作者。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Wed Dec 10 15:03:39 CST 2025, time=2025-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532404, encodeId=2a1d5324048f, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:投过3次,前2次都是3天之内秒拒,这次送审了,一审20多天,只有1个审稿人意见,大修,修回后二审20多天接收。不错的杂志。意外的是还是该期封面文章,不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=574, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ecd71631888, createdName=gly123, createdTime=Thu Feb 02 22:18:00 CST 2017, time=2017-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2245576, encodeId=06f322455e680, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤;基因<br>经验分享:杂志说录取率15%,投稿6天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202404/a5114d14865f42a28d62bef59e7f68b0-90NEwo6wNuqf.jpg, createdBy=976b8410850, createdName=ms3000000397330826, createdTime=Mon Dec 30 13:12:59 CST 2024, time=2024-12-30, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2226050, encodeId=06ef222605029, content=六天被拒稿了,速度挺快的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad709448387, createdName=ms1000001503174164, createdTime=Mon Sep 16 01:44:40 CST 2024, time=2024-09-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1001197, encodeId=e9f8100119e94, content=有没有大佬遇到投稿系统登陆失败的情况呢?一直显示账号密码错误。修改多次依旧报错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIsjYkp2Kl5shib2jnlaftRccumbKXfJaXIoR1f8DoW7czb9LTIicgjkQUujxbibq58SRYQOfT8vc2Ww/0, createdBy=91e52207571, createdName=Doctor.Li, createdTime=Tue Jul 20 17:21:16 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589865, encodeId=1c31589865da, content=同问<span class="quote">hemeifeng2009 2018-10-06 00:00:00 发表:<br>该杂志最近接收本人一篇胃癌相关Meta分析,由于自身但耽误两个月,总历程6个月。 4月23日投稿,6月份杂志给予审稿意见,本人稍有耽误(期限3个月),惭愧,真的3个月整才修回(增加““未来展望”+文章润色)。注意:语言要求程度很高 R.1。 9月初,修稿再投稿,9月中旬审稿意见:增加“详细摘要” R.2。 9月中旬,修稿再投稿,9月底杂志给予审稿意见:要求删除错误引用的一篇文献 R.3。 10月5日,终于收到主编审稿意见,予以接收(accepted revision R.3)。 本人的疑问是: 1.杂志社编辑鼓励作者申请封面,请问各位前辈封面费用一般是多少? 2.杂志投稿说明只要有彩图收费,本稿【黑白图但无彩图、Open Access选择NO】晚辈想进一步请教,没有任何费用对吧?</span>, beContent=hemeifeng2009 2018-10-06 00:00:00 发表: 该杂志最近接收本人一篇胃癌相关Meta分析,由于自身但耽误两个月,总历程6个月。 4月23日投稿,6月份杂志给予审稿意见,本人稍有耽误(期限3个月),惭愧,真的3个月整才修回(增加““未来展望”+文章润色)。注意:语言要求程度很高 R.1。 9月初,修稿再投稿,9月中旬审稿意见:增加“详细摘要” R.2。 9月中旬,修稿再投稿,9月底杂志给予审稿意见:要求删除错误引用的一篇文献 R.3。 10月5日,终于收到主编审稿意见,予以接收(accepted revision R.3)。 本人的疑问是: 1.杂志社编辑鼓励作者申请封面,请问各位前辈封面费用一般是多少? 2.杂志投稿说明只要有彩图收费,本稿【黑白图但无彩图、Open Access选择NO】晚辈想进一步请教,没有任何费用对吧?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c01577709, createdName=zhanyu, createdTime=Tue Apr 28 00:00:00 CST 2020, time=2020-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109602, encodeId=4b5b2109602c5, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肝癌<br>经验分享:2023.1.6投稿,1.9拒稿,,,审稿是够快的,理由也不给一个。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32418460254, createdName=ms3000000907122076, createdTime=Tue Jan 10 00:46:10 CST 2023, time=2023-01-10, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2108068, encodeId=a765210806830, content=偏重的研究方向:肿瘤;癌症;预后<br>经验分享:11.30投稿unde r review 12.29一审意见回来,副主编和一个审稿人分别提了一个意见,给了3个月修改时间,已返修过去,期待好结果,总体速度很快了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8775398331, createdName=ms5000000029332336, createdTime=Thu Dec 29 20:34:08 CST 2022, time=2022-12-29, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2097425, encodeId=23e8209e425d9, content=请问这个杂志有选项可以不收版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a235198854, createdName=14735239m04暂无昵称, createdTime=Sun Oct 30 08:55:48 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097473, encodeId=a6f5209e4730f, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:癌症;临床<br>经验分享:<a href='/topic/show?id=5769104e42a9' target=_blank style='color:#2F92EE;'>#临床回顾性分析#</a> 【HU】投稿经验分享 赠人玫瑰🌹 10-1submitted 10-1 under review 10-27 awaiting EIC Decision 10-29 Reject Reject letter具体内容如下: Your manuscript entitled, "..........," (JSO-2022-....) was reviewed by the Editorial Committee of Journal of Surgical Oncology. After careful consideration, the manuscript was not recommended for publication in the Journal. This decision reflects the priority that the manuscript was assigned in relation to competing submissions. 总结:审稿较快,偏向于临床大样本研究,病例数低于100的回顾性分析基本不收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104742, encryptionId=5769104e42a9, topicName=临床回顾性分析)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210222/80bdeec0f3f34445aac0344bb5d0ca22/eafe07d5604f4c0a85d42d0f35be2184.jpg, createdBy=2ae15443834, createdName=小白先生, createdTime=Sun Oct 30 15:14:09 CST 2022, time=2022-10-30, status=1, ipAttribution=)]
    2024-12-30 ms3000000397330826 来自河北省

    审稿速度:1.0 | 投稿命中率:5.0
    偏重的研究方向:肿瘤;基因
    经验分享:杂志说录取率15%,投稿6天

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2292690, encodeId=6240229269039, content=稿约:每份手稿仅允许一名(1)名通讯作者。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Wed Dec 10 15:03:39 CST 2025, time=2025-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532404, encodeId=2a1d5324048f, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:投过3次,前2次都是3天之内秒拒,这次送审了,一审20多天,只有1个审稿人意见,大修,修回后二审20多天接收。不错的杂志。意外的是还是该期封面文章,不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=574, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ecd71631888, createdName=gly123, createdTime=Thu Feb 02 22:18:00 CST 2017, time=2017-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2245576, encodeId=06f322455e680, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤;基因<br>经验分享:杂志说录取率15%,投稿6天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202404/a5114d14865f42a28d62bef59e7f68b0-90NEwo6wNuqf.jpg, createdBy=976b8410850, createdName=ms3000000397330826, createdTime=Mon Dec 30 13:12:59 CST 2024, time=2024-12-30, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2226050, encodeId=06ef222605029, content=六天被拒稿了,速度挺快的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad709448387, createdName=ms1000001503174164, createdTime=Mon Sep 16 01:44:40 CST 2024, time=2024-09-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1001197, encodeId=e9f8100119e94, content=有没有大佬遇到投稿系统登陆失败的情况呢?一直显示账号密码错误。修改多次依旧报错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIsjYkp2Kl5shib2jnlaftRccumbKXfJaXIoR1f8DoW7czb9LTIicgjkQUujxbibq58SRYQOfT8vc2Ww/0, createdBy=91e52207571, createdName=Doctor.Li, createdTime=Tue Jul 20 17:21:16 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589865, encodeId=1c31589865da, content=同问<span class="quote">hemeifeng2009 2018-10-06 00:00:00 发表:<br>该杂志最近接收本人一篇胃癌相关Meta分析,由于自身但耽误两个月,总历程6个月。 4月23日投稿,6月份杂志给予审稿意见,本人稍有耽误(期限3个月),惭愧,真的3个月整才修回(增加““未来展望”+文章润色)。注意:语言要求程度很高 R.1。 9月初,修稿再投稿,9月中旬审稿意见:增加“详细摘要” R.2。 9月中旬,修稿再投稿,9月底杂志给予审稿意见:要求删除错误引用的一篇文献 R.3。 10月5日,终于收到主编审稿意见,予以接收(accepted revision R.3)。 本人的疑问是: 1.杂志社编辑鼓励作者申请封面,请问各位前辈封面费用一般是多少? 2.杂志投稿说明只要有彩图收费,本稿【黑白图但无彩图、Open Access选择NO】晚辈想进一步请教,没有任何费用对吧?</span>, beContent=hemeifeng2009 2018-10-06 00:00:00 发表: 该杂志最近接收本人一篇胃癌相关Meta分析,由于自身但耽误两个月,总历程6个月。 4月23日投稿,6月份杂志给予审稿意见,本人稍有耽误(期限3个月),惭愧,真的3个月整才修回(增加““未来展望”+文章润色)。注意:语言要求程度很高 R.1。 9月初,修稿再投稿,9月中旬审稿意见:增加“详细摘要” R.2。 9月中旬,修稿再投稿,9月底杂志给予审稿意见:要求删除错误引用的一篇文献 R.3。 10月5日,终于收到主编审稿意见,予以接收(accepted revision R.3)。 本人的疑问是: 1.杂志社编辑鼓励作者申请封面,请问各位前辈封面费用一般是多少? 2.杂志投稿说明只要有彩图收费,本稿【黑白图但无彩图、Open Access选择NO】晚辈想进一步请教,没有任何费用对吧?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c01577709, createdName=zhanyu, createdTime=Tue Apr 28 00:00:00 CST 2020, time=2020-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109602, encodeId=4b5b2109602c5, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肝癌<br>经验分享:2023.1.6投稿,1.9拒稿,,,审稿是够快的,理由也不给一个。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32418460254, createdName=ms3000000907122076, createdTime=Tue Jan 10 00:46:10 CST 2023, time=2023-01-10, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2108068, encodeId=a765210806830, content=偏重的研究方向:肿瘤;癌症;预后<br>经验分享:11.30投稿unde r review 12.29一审意见回来,副主编和一个审稿人分别提了一个意见,给了3个月修改时间,已返修过去,期待好结果,总体速度很快了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8775398331, createdName=ms5000000029332336, createdTime=Thu Dec 29 20:34:08 CST 2022, time=2022-12-29, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2097425, encodeId=23e8209e425d9, content=请问这个杂志有选项可以不收版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a235198854, createdName=14735239m04暂无昵称, createdTime=Sun Oct 30 08:55:48 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097473, encodeId=a6f5209e4730f, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:癌症;临床<br>经验分享:<a href='/topic/show?id=5769104e42a9' target=_blank style='color:#2F92EE;'>#临床回顾性分析#</a> 【HU】投稿经验分享 赠人玫瑰🌹 10-1submitted 10-1 under review 10-27 awaiting EIC Decision 10-29 Reject Reject letter具体内容如下: Your manuscript entitled, "..........," (JSO-2022-....) was reviewed by the Editorial Committee of Journal of Surgical Oncology. After careful consideration, the manuscript was not recommended for publication in the Journal. This decision reflects the priority that the manuscript was assigned in relation to competing submissions. 总结:审稿较快,偏向于临床大样本研究,病例数低于100的回顾性分析基本不收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104742, encryptionId=5769104e42a9, topicName=临床回顾性分析)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210222/80bdeec0f3f34445aac0344bb5d0ca22/eafe07d5604f4c0a85d42d0f35be2184.jpg, createdBy=2ae15443834, createdName=小白先生, createdTime=Sun Oct 30 15:14:09 CST 2022, time=2022-10-30, status=1, ipAttribution=)]
    2024-09-16 ms1000001503174164 来自江苏省

    六天被拒稿了,速度挺快的

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2292690, encodeId=6240229269039, content=稿约:每份手稿仅允许一名(1)名通讯作者。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Wed Dec 10 15:03:39 CST 2025, time=2025-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532404, encodeId=2a1d5324048f, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:投过3次,前2次都是3天之内秒拒,这次送审了,一审20多天,只有1个审稿人意见,大修,修回后二审20多天接收。不错的杂志。意外的是还是该期封面文章,不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=574, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ecd71631888, createdName=gly123, createdTime=Thu Feb 02 22:18:00 CST 2017, time=2017-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2245576, encodeId=06f322455e680, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤;基因<br>经验分享:杂志说录取率15%,投稿6天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202404/a5114d14865f42a28d62bef59e7f68b0-90NEwo6wNuqf.jpg, createdBy=976b8410850, createdName=ms3000000397330826, createdTime=Mon Dec 30 13:12:59 CST 2024, time=2024-12-30, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2226050, encodeId=06ef222605029, content=六天被拒稿了,速度挺快的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad709448387, createdName=ms1000001503174164, createdTime=Mon Sep 16 01:44:40 CST 2024, time=2024-09-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1001197, encodeId=e9f8100119e94, content=有没有大佬遇到投稿系统登陆失败的情况呢?一直显示账号密码错误。修改多次依旧报错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIsjYkp2Kl5shib2jnlaftRccumbKXfJaXIoR1f8DoW7czb9LTIicgjkQUujxbibq58SRYQOfT8vc2Ww/0, createdBy=91e52207571, createdName=Doctor.Li, createdTime=Tue Jul 20 17:21:16 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589865, encodeId=1c31589865da, content=同问<span class="quote">hemeifeng2009 2018-10-06 00:00:00 发表:<br>该杂志最近接收本人一篇胃癌相关Meta分析,由于自身但耽误两个月,总历程6个月。 4月23日投稿,6月份杂志给予审稿意见,本人稍有耽误(期限3个月),惭愧,真的3个月整才修回(增加““未来展望”+文章润色)。注意:语言要求程度很高 R.1。 9月初,修稿再投稿,9月中旬审稿意见:增加“详细摘要” R.2。 9月中旬,修稿再投稿,9月底杂志给予审稿意见:要求删除错误引用的一篇文献 R.3。 10月5日,终于收到主编审稿意见,予以接收(accepted revision R.3)。 本人的疑问是: 1.杂志社编辑鼓励作者申请封面,请问各位前辈封面费用一般是多少? 2.杂志投稿说明只要有彩图收费,本稿【黑白图但无彩图、Open Access选择NO】晚辈想进一步请教,没有任何费用对吧?</span>, beContent=hemeifeng2009 2018-10-06 00:00:00 发表: 该杂志最近接收本人一篇胃癌相关Meta分析,由于自身但耽误两个月,总历程6个月。 4月23日投稿,6月份杂志给予审稿意见,本人稍有耽误(期限3个月),惭愧,真的3个月整才修回(增加““未来展望”+文章润色)。注意:语言要求程度很高 R.1。 9月初,修稿再投稿,9月中旬审稿意见:增加“详细摘要” R.2。 9月中旬,修稿再投稿,9月底杂志给予审稿意见:要求删除错误引用的一篇文献 R.3。 10月5日,终于收到主编审稿意见,予以接收(accepted revision R.3)。 本人的疑问是: 1.杂志社编辑鼓励作者申请封面,请问各位前辈封面费用一般是多少? 2.杂志投稿说明只要有彩图收费,本稿【黑白图但无彩图、Open Access选择NO】晚辈想进一步请教,没有任何费用对吧?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c01577709, createdName=zhanyu, createdTime=Tue Apr 28 00:00:00 CST 2020, time=2020-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109602, encodeId=4b5b2109602c5, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肝癌<br>经验分享:2023.1.6投稿,1.9拒稿,,,审稿是够快的,理由也不给一个。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32418460254, createdName=ms3000000907122076, createdTime=Tue Jan 10 00:46:10 CST 2023, time=2023-01-10, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2108068, encodeId=a765210806830, content=偏重的研究方向:肿瘤;癌症;预后<br>经验分享:11.30投稿unde r review 12.29一审意见回来,副主编和一个审稿人分别提了一个意见,给了3个月修改时间,已返修过去,期待好结果,总体速度很快了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8775398331, createdName=ms5000000029332336, createdTime=Thu Dec 29 20:34:08 CST 2022, time=2022-12-29, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2097425, encodeId=23e8209e425d9, content=请问这个杂志有选项可以不收版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a235198854, createdName=14735239m04暂无昵称, createdTime=Sun Oct 30 08:55:48 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097473, encodeId=a6f5209e4730f, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:癌症;临床<br>经验分享:<a href='/topic/show?id=5769104e42a9' target=_blank style='color:#2F92EE;'>#临床回顾性分析#</a> 【HU】投稿经验分享 赠人玫瑰🌹 10-1submitted 10-1 under review 10-27 awaiting EIC Decision 10-29 Reject Reject letter具体内容如下: Your manuscript entitled, "..........," (JSO-2022-....) was reviewed by the Editorial Committee of Journal of Surgical Oncology. After careful consideration, the manuscript was not recommended for publication in the Journal. This decision reflects the priority that the manuscript was assigned in relation to competing submissions. 总结:审稿较快,偏向于临床大样本研究,病例数低于100的回顾性分析基本不收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104742, encryptionId=5769104e42a9, topicName=临床回顾性分析)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210222/80bdeec0f3f34445aac0344bb5d0ca22/eafe07d5604f4c0a85d42d0f35be2184.jpg, createdBy=2ae15443834, createdName=小白先生, createdTime=Sun Oct 30 15:14:09 CST 2022, time=2022-10-30, status=1, ipAttribution=)]
    2021-07-20 Doctor.Li

    有没有大佬遇到投稿系统登陆失败的情况呢?一直显示账号密码错误。修改多次依旧报错

    2

    展开2条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2292690, encodeId=6240229269039, content=稿约:每份手稿仅允许一名(1)名通讯作者。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Wed Dec 10 15:03:39 CST 2025, time=2025-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532404, encodeId=2a1d5324048f, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:投过3次,前2次都是3天之内秒拒,这次送审了,一审20多天,只有1个审稿人意见,大修,修回后二审20多天接收。不错的杂志。意外的是还是该期封面文章,不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=574, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ecd71631888, createdName=gly123, createdTime=Thu Feb 02 22:18:00 CST 2017, time=2017-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2245576, encodeId=06f322455e680, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤;基因<br>经验分享:杂志说录取率15%,投稿6天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202404/a5114d14865f42a28d62bef59e7f68b0-90NEwo6wNuqf.jpg, createdBy=976b8410850, createdName=ms3000000397330826, createdTime=Mon Dec 30 13:12:59 CST 2024, time=2024-12-30, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2226050, encodeId=06ef222605029, content=六天被拒稿了,速度挺快的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad709448387, createdName=ms1000001503174164, createdTime=Mon Sep 16 01:44:40 CST 2024, time=2024-09-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1001197, encodeId=e9f8100119e94, content=有没有大佬遇到投稿系统登陆失败的情况呢?一直显示账号密码错误。修改多次依旧报错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIsjYkp2Kl5shib2jnlaftRccumbKXfJaXIoR1f8DoW7czb9LTIicgjkQUujxbibq58SRYQOfT8vc2Ww/0, createdBy=91e52207571, createdName=Doctor.Li, createdTime=Tue Jul 20 17:21:16 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589865, encodeId=1c31589865da, content=同问<span class="quote">hemeifeng2009 2018-10-06 00:00:00 发表:<br>该杂志最近接收本人一篇胃癌相关Meta分析,由于自身但耽误两个月,总历程6个月。 4月23日投稿,6月份杂志给予审稿意见,本人稍有耽误(期限3个月),惭愧,真的3个月整才修回(增加““未来展望”+文章润色)。注意:语言要求程度很高 R.1。 9月初,修稿再投稿,9月中旬审稿意见:增加“详细摘要” R.2。 9月中旬,修稿再投稿,9月底杂志给予审稿意见:要求删除错误引用的一篇文献 R.3。 10月5日,终于收到主编审稿意见,予以接收(accepted revision R.3)。 本人的疑问是: 1.杂志社编辑鼓励作者申请封面,请问各位前辈封面费用一般是多少? 2.杂志投稿说明只要有彩图收费,本稿【黑白图但无彩图、Open Access选择NO】晚辈想进一步请教,没有任何费用对吧?</span>, beContent=hemeifeng2009 2018-10-06 00:00:00 发表: 该杂志最近接收本人一篇胃癌相关Meta分析,由于自身但耽误两个月,总历程6个月。 4月23日投稿,6月份杂志给予审稿意见,本人稍有耽误(期限3个月),惭愧,真的3个月整才修回(增加““未来展望”+文章润色)。注意:语言要求程度很高 R.1。 9月初,修稿再投稿,9月中旬审稿意见:增加“详细摘要” R.2。 9月中旬,修稿再投稿,9月底杂志给予审稿意见:要求删除错误引用的一篇文献 R.3。 10月5日,终于收到主编审稿意见,予以接收(accepted revision R.3)。 本人的疑问是: 1.杂志社编辑鼓励作者申请封面,请问各位前辈封面费用一般是多少? 2.杂志投稿说明只要有彩图收费,本稿【黑白图但无彩图、Open Access选择NO】晚辈想进一步请教,没有任何费用对吧?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c01577709, createdName=zhanyu, createdTime=Tue Apr 28 00:00:00 CST 2020, time=2020-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109602, encodeId=4b5b2109602c5, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肝癌<br>经验分享:2023.1.6投稿,1.9拒稿,,,审稿是够快的,理由也不给一个。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32418460254, createdName=ms3000000907122076, createdTime=Tue Jan 10 00:46:10 CST 2023, time=2023-01-10, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2108068, encodeId=a765210806830, content=偏重的研究方向:肿瘤;癌症;预后<br>经验分享:11.30投稿unde r review 12.29一审意见回来,副主编和一个审稿人分别提了一个意见,给了3个月修改时间,已返修过去,期待好结果,总体速度很快了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8775398331, createdName=ms5000000029332336, createdTime=Thu Dec 29 20:34:08 CST 2022, time=2022-12-29, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2097425, encodeId=23e8209e425d9, content=请问这个杂志有选项可以不收版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a235198854, createdName=14735239m04暂无昵称, createdTime=Sun Oct 30 08:55:48 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097473, encodeId=a6f5209e4730f, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:癌症;临床<br>经验分享:<a href='/topic/show?id=5769104e42a9' target=_blank style='color:#2F92EE;'>#临床回顾性分析#</a> 【HU】投稿经验分享 赠人玫瑰🌹 10-1submitted 10-1 under review 10-27 awaiting EIC Decision 10-29 Reject Reject letter具体内容如下: Your manuscript entitled, "..........," (JSO-2022-....) was reviewed by the Editorial Committee of Journal of Surgical Oncology. After careful consideration, the manuscript was not recommended for publication in the Journal. This decision reflects the priority that the manuscript was assigned in relation to competing submissions. 总结:审稿较快,偏向于临床大样本研究,病例数低于100的回顾性分析基本不收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104742, encryptionId=5769104e42a9, topicName=临床回顾性分析)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210222/80bdeec0f3f34445aac0344bb5d0ca22/eafe07d5604f4c0a85d42d0f35be2184.jpg, createdBy=2ae15443834, createdName=小白先生, createdTime=Sun Oct 30 15:14:09 CST 2022, time=2022-10-30, status=1, ipAttribution=)]
    2020-04-28 zhanyu

    同问hemeifeng2009 2018-10-06 00:00:00 发表:
    该杂志最近接收本人一篇胃癌相关Meta分析,由于自身但耽误两个月,总历程6个月。 4月23日投稿,6月份杂志给予审稿意见,本人稍有耽误(期限3个月),惭愧,真的3个月整才修回(增加““未来展望”+文章润色)。注意:语言要求程度很高 R.1。 9月初,修稿再投稿,9月中旬审稿意见:增加“详细摘要” R.2。 9月中旬,修稿再投稿,9月底杂志给予审稿意见:要求删除错误引用的一篇文献 R.3。 10月5日,终于收到主编审稿意见,予以接收(accepted revision R.3)。 本人的疑问是: 1.杂志社编辑鼓励作者申请封面,请问各位前辈封面费用一般是多少? 2.杂志投稿说明只要有彩图收费,本稿【黑白图但无彩图、Open Access选择NO】晚辈想进一步请教,没有任何费用对吧?

    hemeifeng2009 2018-10-06 00:00:00 发表: 该杂志最近接收本人一篇胃癌相关Meta分析,由于自身但耽误两个月,总历程6个月。 4月23日投稿,6月份杂志给予审稿意见,本人稍有耽误(期限3个月),惭愧,真的3个月整才修回(增加““未来展望”+文章润色)。注意:语言要求程度很高 R.1。 9月初,修稿再投稿,9月中旬审稿意见:增加“详细摘要” R.2。 9月中旬,修稿再投稿,9月底杂志给予审稿意见:要求删除错误引用的一篇文献 R.3。 10月5日,终于收到主编审稿意见,予以接收(accepted revision R.3)。 本人的疑问是: 1.杂志社编辑鼓励作者申请封面,请问各位前辈封面费用一般是多少? 2.杂志投稿说明只要有彩图收费,本稿【黑白图但无彩图、Open Access选择NO】晚辈想进一步请教,没有任何费用对吧?

    2

    展开2条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2292690, encodeId=6240229269039, content=稿约:每份手稿仅允许一名(1)名通讯作者。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Wed Dec 10 15:03:39 CST 2025, time=2025-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532404, encodeId=2a1d5324048f, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:投过3次,前2次都是3天之内秒拒,这次送审了,一审20多天,只有1个审稿人意见,大修,修回后二审20多天接收。不错的杂志。意外的是还是该期封面文章,不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=574, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ecd71631888, createdName=gly123, createdTime=Thu Feb 02 22:18:00 CST 2017, time=2017-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2245576, encodeId=06f322455e680, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤;基因<br>经验分享:杂志说录取率15%,投稿6天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202404/a5114d14865f42a28d62bef59e7f68b0-90NEwo6wNuqf.jpg, createdBy=976b8410850, createdName=ms3000000397330826, createdTime=Mon Dec 30 13:12:59 CST 2024, time=2024-12-30, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2226050, encodeId=06ef222605029, content=六天被拒稿了,速度挺快的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad709448387, createdName=ms1000001503174164, createdTime=Mon Sep 16 01:44:40 CST 2024, time=2024-09-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1001197, encodeId=e9f8100119e94, content=有没有大佬遇到投稿系统登陆失败的情况呢?一直显示账号密码错误。修改多次依旧报错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIsjYkp2Kl5shib2jnlaftRccumbKXfJaXIoR1f8DoW7czb9LTIicgjkQUujxbibq58SRYQOfT8vc2Ww/0, createdBy=91e52207571, createdName=Doctor.Li, createdTime=Tue Jul 20 17:21:16 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589865, encodeId=1c31589865da, content=同问<span class="quote">hemeifeng2009 2018-10-06 00:00:00 发表:<br>该杂志最近接收本人一篇胃癌相关Meta分析,由于自身但耽误两个月,总历程6个月。 4月23日投稿,6月份杂志给予审稿意见,本人稍有耽误(期限3个月),惭愧,真的3个月整才修回(增加““未来展望”+文章润色)。注意:语言要求程度很高 R.1。 9月初,修稿再投稿,9月中旬审稿意见:增加“详细摘要” R.2。 9月中旬,修稿再投稿,9月底杂志给予审稿意见:要求删除错误引用的一篇文献 R.3。 10月5日,终于收到主编审稿意见,予以接收(accepted revision R.3)。 本人的疑问是: 1.杂志社编辑鼓励作者申请封面,请问各位前辈封面费用一般是多少? 2.杂志投稿说明只要有彩图收费,本稿【黑白图但无彩图、Open Access选择NO】晚辈想进一步请教,没有任何费用对吧?</span>, beContent=hemeifeng2009 2018-10-06 00:00:00 发表: 该杂志最近接收本人一篇胃癌相关Meta分析,由于自身但耽误两个月,总历程6个月。 4月23日投稿,6月份杂志给予审稿意见,本人稍有耽误(期限3个月),惭愧,真的3个月整才修回(增加““未来展望”+文章润色)。注意:语言要求程度很高 R.1。 9月初,修稿再投稿,9月中旬审稿意见:增加“详细摘要” R.2。 9月中旬,修稿再投稿,9月底杂志给予审稿意见:要求删除错误引用的一篇文献 R.3。 10月5日,终于收到主编审稿意见,予以接收(accepted revision R.3)。 本人的疑问是: 1.杂志社编辑鼓励作者申请封面,请问各位前辈封面费用一般是多少? 2.杂志投稿说明只要有彩图收费,本稿【黑白图但无彩图、Open Access选择NO】晚辈想进一步请教,没有任何费用对吧?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c01577709, createdName=zhanyu, createdTime=Tue Apr 28 00:00:00 CST 2020, time=2020-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109602, encodeId=4b5b2109602c5, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肝癌<br>经验分享:2023.1.6投稿,1.9拒稿,,,审稿是够快的,理由也不给一个。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32418460254, createdName=ms3000000907122076, createdTime=Tue Jan 10 00:46:10 CST 2023, time=2023-01-10, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2108068, encodeId=a765210806830, content=偏重的研究方向:肿瘤;癌症;预后<br>经验分享:11.30投稿unde r review 12.29一审意见回来,副主编和一个审稿人分别提了一个意见,给了3个月修改时间,已返修过去,期待好结果,总体速度很快了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8775398331, createdName=ms5000000029332336, createdTime=Thu Dec 29 20:34:08 CST 2022, time=2022-12-29, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2097425, encodeId=23e8209e425d9, content=请问这个杂志有选项可以不收版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a235198854, createdName=14735239m04暂无昵称, createdTime=Sun Oct 30 08:55:48 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097473, encodeId=a6f5209e4730f, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:癌症;临床<br>经验分享:<a href='/topic/show?id=5769104e42a9' target=_blank style='color:#2F92EE;'>#临床回顾性分析#</a> 【HU】投稿经验分享 赠人玫瑰🌹 10-1submitted 10-1 under review 10-27 awaiting EIC Decision 10-29 Reject Reject letter具体内容如下: Your manuscript entitled, "..........," (JSO-2022-....) was reviewed by the Editorial Committee of Journal of Surgical Oncology. After careful consideration, the manuscript was not recommended for publication in the Journal. This decision reflects the priority that the manuscript was assigned in relation to competing submissions. 总结:审稿较快,偏向于临床大样本研究,病例数低于100的回顾性分析基本不收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104742, encryptionId=5769104e42a9, topicName=临床回顾性分析)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210222/80bdeec0f3f34445aac0344bb5d0ca22/eafe07d5604f4c0a85d42d0f35be2184.jpg, createdBy=2ae15443834, createdName=小白先生, createdTime=Sun Oct 30 15:14:09 CST 2022, time=2022-10-30, status=1, ipAttribution=)]
    2023-01-10 ms3000000907122076 来自广西

    审稿速度:1.0 | 投稿命中率:25.0
    偏重的研究方向:肝癌
    经验分享:2023.1.6投稿,1.9拒稿,,,审稿是够快的,理由也不给一个。。。

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2292690, encodeId=6240229269039, content=稿约:每份手稿仅允许一名(1)名通讯作者。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Wed Dec 10 15:03:39 CST 2025, time=2025-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532404, encodeId=2a1d5324048f, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:投过3次,前2次都是3天之内秒拒,这次送审了,一审20多天,只有1个审稿人意见,大修,修回后二审20多天接收。不错的杂志。意外的是还是该期封面文章,不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=574, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ecd71631888, createdName=gly123, createdTime=Thu Feb 02 22:18:00 CST 2017, time=2017-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2245576, encodeId=06f322455e680, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤;基因<br>经验分享:杂志说录取率15%,投稿6天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202404/a5114d14865f42a28d62bef59e7f68b0-90NEwo6wNuqf.jpg, createdBy=976b8410850, createdName=ms3000000397330826, createdTime=Mon Dec 30 13:12:59 CST 2024, time=2024-12-30, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2226050, encodeId=06ef222605029, content=六天被拒稿了,速度挺快的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad709448387, createdName=ms1000001503174164, createdTime=Mon Sep 16 01:44:40 CST 2024, time=2024-09-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1001197, encodeId=e9f8100119e94, content=有没有大佬遇到投稿系统登陆失败的情况呢?一直显示账号密码错误。修改多次依旧报错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIsjYkp2Kl5shib2jnlaftRccumbKXfJaXIoR1f8DoW7czb9LTIicgjkQUujxbibq58SRYQOfT8vc2Ww/0, createdBy=91e52207571, createdName=Doctor.Li, createdTime=Tue Jul 20 17:21:16 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589865, encodeId=1c31589865da, content=同问<span class="quote">hemeifeng2009 2018-10-06 00:00:00 发表:<br>该杂志最近接收本人一篇胃癌相关Meta分析,由于自身但耽误两个月,总历程6个月。 4月23日投稿,6月份杂志给予审稿意见,本人稍有耽误(期限3个月),惭愧,真的3个月整才修回(增加““未来展望”+文章润色)。注意:语言要求程度很高 R.1。 9月初,修稿再投稿,9月中旬审稿意见:增加“详细摘要” R.2。 9月中旬,修稿再投稿,9月底杂志给予审稿意见:要求删除错误引用的一篇文献 R.3。 10月5日,终于收到主编审稿意见,予以接收(accepted revision R.3)。 本人的疑问是: 1.杂志社编辑鼓励作者申请封面,请问各位前辈封面费用一般是多少? 2.杂志投稿说明只要有彩图收费,本稿【黑白图但无彩图、Open Access选择NO】晚辈想进一步请教,没有任何费用对吧?</span>, beContent=hemeifeng2009 2018-10-06 00:00:00 发表: 该杂志最近接收本人一篇胃癌相关Meta分析,由于自身但耽误两个月,总历程6个月。 4月23日投稿,6月份杂志给予审稿意见,本人稍有耽误(期限3个月),惭愧,真的3个月整才修回(增加““未来展望”+文章润色)。注意:语言要求程度很高 R.1。 9月初,修稿再投稿,9月中旬审稿意见:增加“详细摘要” R.2。 9月中旬,修稿再投稿,9月底杂志给予审稿意见:要求删除错误引用的一篇文献 R.3。 10月5日,终于收到主编审稿意见,予以接收(accepted revision R.3)。 本人的疑问是: 1.杂志社编辑鼓励作者申请封面,请问各位前辈封面费用一般是多少? 2.杂志投稿说明只要有彩图收费,本稿【黑白图但无彩图、Open Access选择NO】晚辈想进一步请教,没有任何费用对吧?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c01577709, createdName=zhanyu, createdTime=Tue Apr 28 00:00:00 CST 2020, time=2020-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109602, encodeId=4b5b2109602c5, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肝癌<br>经验分享:2023.1.6投稿,1.9拒稿,,,审稿是够快的,理由也不给一个。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32418460254, createdName=ms3000000907122076, createdTime=Tue Jan 10 00:46:10 CST 2023, time=2023-01-10, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2108068, encodeId=a765210806830, content=偏重的研究方向:肿瘤;癌症;预后<br>经验分享:11.30投稿unde r review 12.29一审意见回来,副主编和一个审稿人分别提了一个意见,给了3个月修改时间,已返修过去,期待好结果,总体速度很快了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8775398331, createdName=ms5000000029332336, createdTime=Thu Dec 29 20:34:08 CST 2022, time=2022-12-29, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2097425, encodeId=23e8209e425d9, content=请问这个杂志有选项可以不收版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a235198854, createdName=14735239m04暂无昵称, createdTime=Sun Oct 30 08:55:48 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097473, encodeId=a6f5209e4730f, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:癌症;临床<br>经验分享:<a href='/topic/show?id=5769104e42a9' target=_blank style='color:#2F92EE;'>#临床回顾性分析#</a> 【HU】投稿经验分享 赠人玫瑰🌹 10-1submitted 10-1 under review 10-27 awaiting EIC Decision 10-29 Reject Reject letter具体内容如下: Your manuscript entitled, "..........," (JSO-2022-....) was reviewed by the Editorial Committee of Journal of Surgical Oncology. After careful consideration, the manuscript was not recommended for publication in the Journal. This decision reflects the priority that the manuscript was assigned in relation to competing submissions. 总结:审稿较快,偏向于临床大样本研究,病例数低于100的回顾性分析基本不收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104742, encryptionId=5769104e42a9, topicName=临床回顾性分析)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210222/80bdeec0f3f34445aac0344bb5d0ca22/eafe07d5604f4c0a85d42d0f35be2184.jpg, createdBy=2ae15443834, createdName=小白先生, createdTime=Sun Oct 30 15:14:09 CST 2022, time=2022-10-30, status=1, ipAttribution=)]
    2022-12-29 ms5000000029332336 来自辽宁省

    偏重的研究方向:肿瘤;癌症;预后
    经验分享:11.30投稿unde r review 12.29一审意见回来,副主编和一个审稿人分别提了一个意见,给了3个月修改时间,已返修过去,期待好结果,总体速度很快了。

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2292690, encodeId=6240229269039, content=稿约:每份手稿仅允许一名(1)名通讯作者。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Wed Dec 10 15:03:39 CST 2025, time=2025-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532404, encodeId=2a1d5324048f, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:投过3次,前2次都是3天之内秒拒,这次送审了,一审20多天,只有1个审稿人意见,大修,修回后二审20多天接收。不错的杂志。意外的是还是该期封面文章,不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=574, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ecd71631888, createdName=gly123, createdTime=Thu Feb 02 22:18:00 CST 2017, time=2017-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2245576, encodeId=06f322455e680, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤;基因<br>经验分享:杂志说录取率15%,投稿6天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202404/a5114d14865f42a28d62bef59e7f68b0-90NEwo6wNuqf.jpg, createdBy=976b8410850, createdName=ms3000000397330826, createdTime=Mon Dec 30 13:12:59 CST 2024, time=2024-12-30, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2226050, encodeId=06ef222605029, content=六天被拒稿了,速度挺快的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad709448387, createdName=ms1000001503174164, createdTime=Mon Sep 16 01:44:40 CST 2024, time=2024-09-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1001197, encodeId=e9f8100119e94, content=有没有大佬遇到投稿系统登陆失败的情况呢?一直显示账号密码错误。修改多次依旧报错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIsjYkp2Kl5shib2jnlaftRccumbKXfJaXIoR1f8DoW7czb9LTIicgjkQUujxbibq58SRYQOfT8vc2Ww/0, createdBy=91e52207571, createdName=Doctor.Li, createdTime=Tue Jul 20 17:21:16 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589865, encodeId=1c31589865da, content=同问<span class="quote">hemeifeng2009 2018-10-06 00:00:00 发表:<br>该杂志最近接收本人一篇胃癌相关Meta分析,由于自身但耽误两个月,总历程6个月。 4月23日投稿,6月份杂志给予审稿意见,本人稍有耽误(期限3个月),惭愧,真的3个月整才修回(增加““未来展望”+文章润色)。注意:语言要求程度很高 R.1。 9月初,修稿再投稿,9月中旬审稿意见:增加“详细摘要” R.2。 9月中旬,修稿再投稿,9月底杂志给予审稿意见:要求删除错误引用的一篇文献 R.3。 10月5日,终于收到主编审稿意见,予以接收(accepted revision R.3)。 本人的疑问是: 1.杂志社编辑鼓励作者申请封面,请问各位前辈封面费用一般是多少? 2.杂志投稿说明只要有彩图收费,本稿【黑白图但无彩图、Open Access选择NO】晚辈想进一步请教,没有任何费用对吧?</span>, beContent=hemeifeng2009 2018-10-06 00:00:00 发表: 该杂志最近接收本人一篇胃癌相关Meta分析,由于自身但耽误两个月,总历程6个月。 4月23日投稿,6月份杂志给予审稿意见,本人稍有耽误(期限3个月),惭愧,真的3个月整才修回(增加““未来展望”+文章润色)。注意:语言要求程度很高 R.1。 9月初,修稿再投稿,9月中旬审稿意见:增加“详细摘要” R.2。 9月中旬,修稿再投稿,9月底杂志给予审稿意见:要求删除错误引用的一篇文献 R.3。 10月5日,终于收到主编审稿意见,予以接收(accepted revision R.3)。 本人的疑问是: 1.杂志社编辑鼓励作者申请封面,请问各位前辈封面费用一般是多少? 2.杂志投稿说明只要有彩图收费,本稿【黑白图但无彩图、Open Access选择NO】晚辈想进一步请教,没有任何费用对吧?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c01577709, createdName=zhanyu, createdTime=Tue Apr 28 00:00:00 CST 2020, time=2020-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109602, encodeId=4b5b2109602c5, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肝癌<br>经验分享:2023.1.6投稿,1.9拒稿,,,审稿是够快的,理由也不给一个。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32418460254, createdName=ms3000000907122076, createdTime=Tue Jan 10 00:46:10 CST 2023, time=2023-01-10, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2108068, encodeId=a765210806830, content=偏重的研究方向:肿瘤;癌症;预后<br>经验分享:11.30投稿unde r review 12.29一审意见回来,副主编和一个审稿人分别提了一个意见,给了3个月修改时间,已返修过去,期待好结果,总体速度很快了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8775398331, createdName=ms5000000029332336, createdTime=Thu Dec 29 20:34:08 CST 2022, time=2022-12-29, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2097425, encodeId=23e8209e425d9, content=请问这个杂志有选项可以不收版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a235198854, createdName=14735239m04暂无昵称, createdTime=Sun Oct 30 08:55:48 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097473, encodeId=a6f5209e4730f, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:癌症;临床<br>经验分享:<a href='/topic/show?id=5769104e42a9' target=_blank style='color:#2F92EE;'>#临床回顾性分析#</a> 【HU】投稿经验分享 赠人玫瑰🌹 10-1submitted 10-1 under review 10-27 awaiting EIC Decision 10-29 Reject Reject letter具体内容如下: Your manuscript entitled, "..........," (JSO-2022-....) was reviewed by the Editorial Committee of Journal of Surgical Oncology. After careful consideration, the manuscript was not recommended for publication in the Journal. This decision reflects the priority that the manuscript was assigned in relation to competing submissions. 总结:审稿较快,偏向于临床大样本研究,病例数低于100的回顾性分析基本不收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104742, encryptionId=5769104e42a9, topicName=临床回顾性分析)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210222/80bdeec0f3f34445aac0344bb5d0ca22/eafe07d5604f4c0a85d42d0f35be2184.jpg, createdBy=2ae15443834, createdName=小白先生, createdTime=Sun Oct 30 15:14:09 CST 2022, time=2022-10-30, status=1, ipAttribution=)]
    2022-10-30 14735239m04暂无昵称

    请问这个杂志有选项可以不收版面费吗

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2292690, encodeId=6240229269039, content=稿约:每份手稿仅允许一名(1)名通讯作者。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Wed Dec 10 15:03:39 CST 2025, time=2025-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532404, encodeId=2a1d5324048f, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:投过3次,前2次都是3天之内秒拒,这次送审了,一审20多天,只有1个审稿人意见,大修,修回后二审20多天接收。不错的杂志。意外的是还是该期封面文章,不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=574, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ecd71631888, createdName=gly123, createdTime=Thu Feb 02 22:18:00 CST 2017, time=2017-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2245576, encodeId=06f322455e680, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤;基因<br>经验分享:杂志说录取率15%,投稿6天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202404/a5114d14865f42a28d62bef59e7f68b0-90NEwo6wNuqf.jpg, createdBy=976b8410850, createdName=ms3000000397330826, createdTime=Mon Dec 30 13:12:59 CST 2024, time=2024-12-30, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2226050, encodeId=06ef222605029, content=六天被拒稿了,速度挺快的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad709448387, createdName=ms1000001503174164, createdTime=Mon Sep 16 01:44:40 CST 2024, time=2024-09-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1001197, encodeId=e9f8100119e94, content=有没有大佬遇到投稿系统登陆失败的情况呢?一直显示账号密码错误。修改多次依旧报错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIsjYkp2Kl5shib2jnlaftRccumbKXfJaXIoR1f8DoW7czb9LTIicgjkQUujxbibq58SRYQOfT8vc2Ww/0, createdBy=91e52207571, createdName=Doctor.Li, createdTime=Tue Jul 20 17:21:16 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589865, encodeId=1c31589865da, content=同问<span class="quote">hemeifeng2009 2018-10-06 00:00:00 发表:<br>该杂志最近接收本人一篇胃癌相关Meta分析,由于自身但耽误两个月,总历程6个月。 4月23日投稿,6月份杂志给予审稿意见,本人稍有耽误(期限3个月),惭愧,真的3个月整才修回(增加““未来展望”+文章润色)。注意:语言要求程度很高 R.1。 9月初,修稿再投稿,9月中旬审稿意见:增加“详细摘要” R.2。 9月中旬,修稿再投稿,9月底杂志给予审稿意见:要求删除错误引用的一篇文献 R.3。 10月5日,终于收到主编审稿意见,予以接收(accepted revision R.3)。 本人的疑问是: 1.杂志社编辑鼓励作者申请封面,请问各位前辈封面费用一般是多少? 2.杂志投稿说明只要有彩图收费,本稿【黑白图但无彩图、Open Access选择NO】晚辈想进一步请教,没有任何费用对吧?</span>, beContent=hemeifeng2009 2018-10-06 00:00:00 发表: 该杂志最近接收本人一篇胃癌相关Meta分析,由于自身但耽误两个月,总历程6个月。 4月23日投稿,6月份杂志给予审稿意见,本人稍有耽误(期限3个月),惭愧,真的3个月整才修回(增加““未来展望”+文章润色)。注意:语言要求程度很高 R.1。 9月初,修稿再投稿,9月中旬审稿意见:增加“详细摘要” R.2。 9月中旬,修稿再投稿,9月底杂志给予审稿意见:要求删除错误引用的一篇文献 R.3。 10月5日,终于收到主编审稿意见,予以接收(accepted revision R.3)。 本人的疑问是: 1.杂志社编辑鼓励作者申请封面,请问各位前辈封面费用一般是多少? 2.杂志投稿说明只要有彩图收费,本稿【黑白图但无彩图、Open Access选择NO】晚辈想进一步请教,没有任何费用对吧?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c01577709, createdName=zhanyu, createdTime=Tue Apr 28 00:00:00 CST 2020, time=2020-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109602, encodeId=4b5b2109602c5, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肝癌<br>经验分享:2023.1.6投稿,1.9拒稿,,,审稿是够快的,理由也不给一个。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32418460254, createdName=ms3000000907122076, createdTime=Tue Jan 10 00:46:10 CST 2023, time=2023-01-10, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2108068, encodeId=a765210806830, content=偏重的研究方向:肿瘤;癌症;预后<br>经验分享:11.30投稿unde r review 12.29一审意见回来,副主编和一个审稿人分别提了一个意见,给了3个月修改时间,已返修过去,期待好结果,总体速度很快了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8775398331, createdName=ms5000000029332336, createdTime=Thu Dec 29 20:34:08 CST 2022, time=2022-12-29, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2097425, encodeId=23e8209e425d9, content=请问这个杂志有选项可以不收版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a235198854, createdName=14735239m04暂无昵称, createdTime=Sun Oct 30 08:55:48 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097473, encodeId=a6f5209e4730f, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:癌症;临床<br>经验分享:<a href='/topic/show?id=5769104e42a9' target=_blank style='color:#2F92EE;'>#临床回顾性分析#</a> 【HU】投稿经验分享 赠人玫瑰🌹 10-1submitted 10-1 under review 10-27 awaiting EIC Decision 10-29 Reject Reject letter具体内容如下: Your manuscript entitled, "..........," (JSO-2022-....) was reviewed by the Editorial Committee of Journal of Surgical Oncology. After careful consideration, the manuscript was not recommended for publication in the Journal. This decision reflects the priority that the manuscript was assigned in relation to competing submissions. 总结:审稿较快,偏向于临床大样本研究,病例数低于100的回顾性分析基本不收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104742, encryptionId=5769104e42a9, topicName=临床回顾性分析)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210222/80bdeec0f3f34445aac0344bb5d0ca22/eafe07d5604f4c0a85d42d0f35be2184.jpg, createdBy=2ae15443834, createdName=小白先生, createdTime=Sun Oct 30 15:14:09 CST 2022, time=2022-10-30, status=1, ipAttribution=)]
    2022-10-30 小白先生

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向:癌症;临床
    经验分享:#临床回顾性分析# 【HU】投稿经验分享 赠人玫瑰🌹 10-1submitted 10-1 under review 10-27 awaiting EIC Decision 10-29 Reject Reject letter具体内容如下: Your manuscript entitled, "..........," (JSO-2022-....) was reviewed by the Editorial Committee of Journal of Surgical Oncology. After careful consideration, the manuscript was not recommended for publication in the Journal. This decision reflects the priority that the manuscript was assigned in relation to competing submissions. 总结:审稿较快,偏向于临床大样本研究,病例数低于100的回顾性分析基本不收。

    0

共117条页码: 1/12页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分